3M Company (3M CO) - Q3 2004 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for the period ended September 30, 2004. 3M is a diversified global manufacturer and technology innovator operating in seven business segments: Health Care, Industrial, Display and Graphics, Consumer and Office, Safety, Security and Protection Services, Electro and Communications, and Transportation. The company reported 778.5 million shares of common stock outstanding as of the period end.
Key Financial Metrics
| Metric | Q3 2004 | Q3 2003 | YTD 9M 2004 | YTD 9M 2003 |
|---|---|---|---|---|
| Net Sales | $4,969 million | $4,616 million | $14,920 million | $13,514 million |
| Operating Income | $1,183 million | $1,030 million | $3,486 million | $2,771 million |
| Net Income | $775 million | $663 million | $2,270 million | $1,784 million |
| Diluted EPS | $0.97 | $0.83 | $2.84 | $2.25 |
| Operating Margin | 23.8% | 22.3% | 23.4% | 20.5% |
| Cash from Operations (9M) | $2,959 million | $2,507 million | ||
| Cash & Equivalents | $2,200 million | $1,836 million (Dec 31, 2003) | ||
| Total Debt | $2,661 million | $2,937 million (Dec 31, 2003) | ||
| Net Debt | $461 million | $1,101 million (Dec 31, 2003) |
Material Changes vs. Prior Period
- Sales Growth: Net sales increased 7.6% in Q3 and 10.4% YTD, driven by core volume growth of 5.0% (Q3) and 6.8% (YTD). Six of seven segments posted positive local-currency sales growth in Q3.
- Profitability: Operating income rose 14.9% in Q3 and 25.8% YTD. Margins expanded due to productivity gains, higher volumes, and favorable currency impacts, offsetting rising raw material costs.
- Acquisitions: 3M acquired HighJump Software (Industrial), Hornell Holding AB (Safety), and Info-X Inc. (Health Care) in 2004, contributing to sales growth.
- Legal Settlements: Received $30 million from Corning Inc. related to a 2002 acquisition dispute. Paid $96.5 million to settle the LePage's Inc. lawsuit.
- Shareholder Returns: Repurchased $1.235 billion of common stock YTD and paid $845 million in dividends. Dividends were increased to $0.36 per share in Q1 2004.
Guidance, Outlook, and Risks
- Q4 2004 EPS Impact: Management expects a combined reduction in Q4 diluted EPS of approximately $0.06 due to:
- Tax Legislation: The "American Jobs Creation Act of 2004" is expected to increase the Q4 tax provision by ~$40 million (reducing EPS by ~$0.05) as 3M repatriates foreign earnings.
- Accounting Change: Adoption of EITF 04-08 regarding contingently convertible debt will increase diluted shares by ~6 million, reducing EPS by ~$0.02.
- Outlook: 3M expects its diverse portfolio to drive top-line growth and cash flow despite challenges like rising raw material prices and inventory adjustments in the LCD market.
- Risks:
- Legal Proceedings: Ongoing litigation regarding breast implants, respirator masks/asbestos, and antitrust claims (LePage's). Asbestos liabilities are accrued at $226 million with $444 million in insurance receivables.
- Market Risks: Exposure to foreign currency fluctuations (over 50% of revenue is international) and volatility in oil-derived raw material costs.
- Regulatory: Environmental reviews regarding perfluorooctanyl chemistry in Canada, the EU, and the US.
Investor Verification Checklist
- Q4 Tax Rate: Verify the impact of the repatriation of $800 million in foreign earnings on the full-year 2004 effective tax rate (projected at ~34%).
- Asbestos Liability: Monitor the ratio of accrued liabilities ($226M) to insurance receivables ($444M) and any changes in litigation outcomes.
- Health Care Segment: Confirm the recovery of sales growth in Q4 as the negative year-over-year impact from non-repeating pharmaceutical agreements (Eli Lilly/IVAX) concludes.
- Capital Allocation: Track the remaining $344 million authorized for stock repurchases under the 2004 program.
- Raw Material Costs: Assess the ability to pass on cost increases for oil-derived materials to customers in the coming quarters.